The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Research & Development Programmes

19 Nov 2015 07:00

RNS Number : 2163G
Quadrise Fuels International PLC
19 November 2015
 

19 November 2015

 

Quadrise Fuels International plc

("QFI", "Quadrise" or the "Company")

 

Research & Development Programmes

 

 

Quadrise, the emerging supplier of MSAR, a low cost alternative to heavy fuel oil in the shipping, oil refining and power generation markets, is pleased to provide the following update on its Research & Development programmes.

 

A Collaboration Agreement was executed with the University of Surrey in Guildford (the "University") on 18 November 2015 (the "Agreement") which provides for the shared use of the University's Centre for Petroleum and Surface Chemistry ("CPSC"), an advanced research facility under the supervision of Professor Spencer Taylor within the Department of Chemistry. The consideration payable by Quadrise to the University for the first twelve months under the Agreement, which is renewable annually, is £78,000. As a result, the Company is relocating its primary emulsion fuels research base from Sweden to the UK.

 

In a related development, the existing Quadrise Research Facility ("QRF") in Essex is being expanded to meet anticipated business support requirements and to develop new MSAR formulations in collaboration with the University.

 

The programme at the University will be directed by Professor Taylor, a world class expert on surfactant and emulsion technology with over 20 years' experience in the petroleum industry with BP, undertaking applied research to underpin intellectual property, as well as upstream and downstream businesses. The CPSC has first class facilities and is ideally equipped with additional hardware and expertise to meet QFI's primary and applied research needs.

 

The intellectual property developed from applied research projects under the Agreement will be exclusively owned by Quadrise, whilst any fundamental research/intellectual property developed under the Agreement will be the property of the University, with Quadrise granted a non-exclusive, royalty free licence - with the option of exclusive rights based on a negotiated settlement. Quadrise will have exclusive rights on intellectual property created from jointly conducted research.

 

The overall research programme will be coordinated with the QRF and tightly aligned with future business needs and imperatives to extend and strengthen the Company's existing competitive advantage.

 

In view of these developments, the primary research programme previously coordinated by Dr Simon Craige in Sweden has been transferred to the UK to facilitate cost effective control and coordination. Dr Craige wished to remain domiciled in Scandinavia for personal reasons and left the Company's employment on 31 October 2015, following an amicable contractual separation.

 

Commenting on these developments, Ian Williams, Executive Chairman of QFI, said:

 

"The agreement with the University of Surrey, together with the relocation of primary research and the extension of QRF, results in the consolidation, expansion and strengthening of all our R&D activities to better serve the anticipated future needs of the Company. We are delighted to be working with Professor Taylor and his team, and to have established the framework for a long term relationship with the University."

 

Professor Dulcie Mulholland, Head of the Department of Chemistry, said:

 

"The University of Surrey and the Department of Chemistry are delighted to establish a relationship with Quadrise. Professor Taylor of our Centre for Petroleum and Surface Chemistry is a leading researcher in this field. We look forward to a long, productive relationship with the company"

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

Ian Williams, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

Jason Miles, Chief Operating Officer

 

Nominated Adviser

Smith & Williamson Corporate Finance Limited

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

Broker

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

Alastair Rae

 

Public & Investor Relations

Bell Pottinger

Rollo Crichton-Stuart

+44 (0)20 7861 3232

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFLFWAFISEEF
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.